Cardiovascular precision medicine – A pharmacogenomic perspective
Cambridge Prisms: Precision Medicine · 2023
DOI: 10.1017/pcm.2023.17 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cambridge Prisms: Precision Medicine, 2023. Verfasst von Sandosh Padmanabhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation.
Abstract (Originalsprache)
Precision medicine envisages the integration of an individual’s clinical and biological features obtained from laboratory tests, imaging, high-throughput omics and health records, to drive a personalised approach to diagnosis and treatment with a higher chance of success. As only up to half of patients respond to medication prescribed following the current one-size-fits-all treatment strategy, the need for a more personalised approach is evident. One of the routes to transforming healthcare through precision medicine is pharmacogenomics (PGx). Around 95% of the population is estimated to carry one or more actionable pharmacogenetic variants and over 75% of adults over 50 years old are on a prescription with a known PGx association. Whilst there are compelling examples of pharmacogenomic implementation in clinical practice, the case for cardiovascular PGx is still evolving. In this review, we shall summarise the current status of PGx in cardiovascular diseases and look at the key enablers and barriers to PGx implementation in clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- BHF Glasgow Cardiovascular Research Centre, School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
ORCID-Profile: Sandosh Padmanabhan
Förderung
- British Heart Foundation
Zitieren
APA
Padmanabhan, S., du Toit, C., & Dominiczak, A. F. (2023). Cardiovascular precision medicine – A pharmacogenomic perspective. Cambridge Prisms: Precision Medicine. https://doi.org/10.1017/pcm.2023.17
Vancouver
Padmanabhan S, du Toit C, Dominiczak AF. Cardiovascular precision medicine – A pharmacogenomic perspective. Cambridge Prisms: Precision Medicine. 2023. doi:10.1017/pcm.2023.17
BibTeX
@article{Padmanabhan2023,
author = {Padmanabhan, Sandosh and du Toit, Clea and Dominiczak, Anna F},
title = {Cardiovascular precision medicine – A pharmacogenomic perspective},
journal = {Cambridge Prisms: Precision Medicine},
year = {2023},
doi = {10.1017/pcm.2023.17}
}
EUVIMED